Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06044688
Other study ID # EYEQUE-011
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date October 2023
Est. completion date November 2023

Study information

Verified date September 2023
Source EyeQue Corp.
Contact Noam Sapiens, PhD
Phone 510-455-8168
Email noam.sapiens@eyeque.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Demonstrate that refraction measurements from the device agree with refraction measurements from a phoropter within clinically meaningful limits.


Description:

The primary purpose of this study is to attain scientific objective evidence to support the VisionCheck Indications for Use by demonstrating that refraction measurements from the device agree with refraction measurements from a phoropter within clinically meaningful limits. The Indications for Use are: "The EyeQue VisionCheck automated subjective refraction system provides an estimate of sphere, cylinder, and axis measurements of the eye" Furthermore, the purpose of this study is to attain scientific objective evidence regarding the precision of the VisionCheck device.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 156
Est. completion date November 2023
Est. primary completion date November 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Each participant must meet the following criteria to be enrolled in this study: 1. Participant or legally authorized representative (LAR) is willing and able to give informed consent 2. Participant is willing and able to follow all study procedures and requirements 3. Participant is able to use a smartphone 4. Participant is interested in getting refraction correction measurement 5. Participant is able to speak, read and write English fluently Exclusion Criteria: Participants who meet any of the following criteria will be excluded from the study: 1. Spherical correction >+8D or <-10D (outside the range of the VisionCheck measurement) 2. Astigmatism correction of less than -5D (optometric notation, outside the range of the VisionCheck measurement) 3. Inability to see the red and green lines (may be overlapped to form a, partially, yellow line) through the VisionCheck device 4. Participant does not have the physical dexterity to properly operate the EyeQue VisionCheck device or the EyeQue app on the smartphone in the Investigator's opinion 5. Has initiated any new medication in the two weeks prior to enrolling in this study that, in the best medical judgment of the Investigator, would impact their participation in the study or ability to use the EyeQue VisionCheck device 6. Eye surgery within 12 months prior to enrolling in this study (including Lasik or lens replacement) 7. Using anticholinergic medications (including first-generation antihistamines) or other medications known to affect vision within the greater of three days or five half-lives prior to enrolling in this study 8. Using an investigational drug or approved therapy for investigational use within the greater of three days or five half-lives prior to enrolling in this study 9. Color deficiency (Ishihara pseudoisochromatic plates: Concise 14-plate edition: six or more errors on plates 1-11; the 24-plate edition: seven or more errors on plates 1-15; the 38-plate edition: nine or more errors on plates 1-21) 10. Neurological and developmental conditions that may affect the outcome of the trial including, but not limited to, Multiple Sclerosis (MS), Stroke, Traumatic Brain Injury (TBI), Parkinson's Disease, Alzheimer's Disease, Dementia, Migraines, Optic Neuropathies, Brain Tumors, Hereditary Conditions (such as Leber's hereditary optic neuropathy (LHON) or retinitis pigmentosa), Epilepsy, Diplopia. Investigator discretion shall be applied to any additional conditions not listed. 11. Eye pathologies, including but not limited to: 1. Glaucoma 2. Any macular disease including macular degeneration, macular hole, macular dystrophy, epiretinal membrane, retinal vein occlusion, macular telangiectasia, central serous chorioretinopathy and cystoid macular edema 3. Eye infection (corneal ulcer, corneal infiltrates, superficial punctate keratitis, ocular histoplasmosis syndrome) 4. Keratoconus 5. Diabetic neuropathy/retinopathy 6. Cytomegalovirus retinitis 7. Diabetic macular edema (evidence of fluid) 8. Retinitis pigmentosa 9. Amblyopia (best corrected visual acuity [BCVA] = 20/30) 10. Chronic or acute uveitis (cells and/or flare in the anterior chamber) 11. Strabismus (manifest/latent, exotropia, esotropia, hypertropia, exophoria, and esophoria) 12. Abnormal astigmatism (mild to severe, > 4D) 13. Binocular vision anomalies 14. Chronic dry eye 15. Monovision

Study Design


Related Conditions & MeSH terms


Intervention

Device:
EyeQue VisionCheck
Automated subjective refraction system provides estimates of sphere, cylinder, and axis measurements of the eye.
Phoropter
Standard of care, ophthalmic testing device, used by eye care professionals to measure the refractive error of the eye and determine prescription.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
EyeQue Corp. The Emmes Company, LLC

Outcome

Type Measure Description Time frame Safety issue
Primary Assess agreement between the VisionCheck refraction measurement and a phoropter (standard of care) refraction measurement. Bland-Altman limits of agreement (LoA) for within-eye differences between refraction measurements of sphere, cylinder, and axis obtained from VisionCheck and the subjective phoropter 3 months
Primary Assess total variability and variance components for between- replicates (repeatability) and between-device/operator while adjusting for between-participant and between-site variability. Percent coefficient of variation (%CV) and standard deviation (SD) of refraction measurement outputs in the form of sphere, cylinder, and axis obtained from VisionCheck 3 months
Secondary Assess improvement in visual acuity brought forth by the VisionCheck refraction measurement. 95% upper prediction limit of improvement in visual acuity from refraction measurements obtained from VisionCheck compared to best corrected visual acuity from the subjective phoropter 3 months
Secondary Assess the safety of the VisionCheck device. Adverse events (AEs), serious adverse events (SAEs), adverse device effects (ADEs), serious adverse device effects (SADEs), anticipated and unanticipated serious adverse device effects (ASADEs and USADEs, respectively) 3 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04778501 - PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia N/A
Completed NCT04536571 - Vision Stability and Preference for Soft Toric vs. Soft Spherical Contact Lenses N/A
Completed NCT04613882 - Quantification of the Visual Benefits of Soft Toric Contact Lenses Compared to Soft Spherical Contact Lenses N/A
Completed NCT05039112 - Clinical Comparison of 2 Daily Disposable Toric Soft Contact Lenses N/A
Recruiting NCT05611294 - Contralateral Study of Topography Guided LASIK Versus Small Incision Lenticule Extraction N/A
Completed NCT05633082 - A Clinical Performance of Two Soft Toric Contact Lenses N/A
Not yet recruiting NCT05561296 - Astigmatism Management With Iris-registration Guided Corneal Relaxing Incisions or Toric IOLs During Cataract Surgery N/A
Not yet recruiting NCT05506553 - Comparison of Aspheric Toric Intraocular Lenses for Micro-monovision N/A
Completed NCT02847169 - Clinical Performance of Toric Hydrogel Contact Lenses Following One Week of Daily Wear N/A
Recruiting NCT02618018 - Clinical Evaluation of Efficacy and Stability of AT TORBI 709M 4-haptic Toric IOL in Cataract Surgery N/A
Completed NCT02555098 - A Bilateral Dispensing Clinical Trial of an Sapphire Lens Against Senofilcon A Toric for Astigmatism Lens N/A
Completed NCT02423109 - Bilateral Dispensing Study of Fanfilcon A Toric Versus Enfilcon A Toric Lenses N/A
Completed NCT02551796 - Early Changes Among FLEx, LASIK and FS-LASIK N/A
Completed NCT02550353 - Changes Between Lenticule Extraction and Femtosecond Laser-assisted Laser in Situ Keratomileusis N/A
Completed NCT02248766 - Clinical Performance of Habitual Wearers of Avaira Toric When Refitted With Clariti Toric Lenses N/A
Completed NCT01965288 - Clinical Performance of Biofinity Toric Versus Air Optix for Astigmatism N/A
Completed NCT01857102 - Toric Eye Strain and Stability Study N/A
Withdrawn NCT01680354 - Surgical Correction of Astigmatism N/A
Completed NCT02624791 - Evaluating and Improving Functional Driving Vision of Patients With Astigmatism N/A
Completed NCT01207466 - Evaluation of Two Daily Disposable Contact Lenses for Wearers With Astigmatism N/A